ID

24574

Descripción

Study ID: 100716 Clinical Study ID: NKP100716 Study Title: An open label repeat dose study to investigate the effect of GW597599 (15 mg) and paroxetine (10 mg) given in combination for 15 days on the pharmacokinetics of midazolam and dextromethorphan in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: vestipitant Trade Name: paroxetine and vestipitant Study Indication: Depressive Disorder and Anxiety Disorders Documentation part: Follow-Up Serious Adverse Event, Form D, Investigator Comment Log, Investigator's Statement

Palabras clave

Versiones (1)
  1. 6/8/17 6/8/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

6 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Follow-Up Serious Adverse Event, Form D, Investigator Comment Log, Investigator's Statement

Inglés

GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Follow-Up Serious Adverse Event, Form D, Investigator Comment Log, Investigator's Statement

1 formularios  
Serious Adverse Event (SAE)
Descripción

Serious Adverse Event (SAE)

Alias
UMLS CUI-1
C1519255
Person Reporting SAE
Descripción

person reporting sae

Tipo de datos

text

Alias
UMLS CUI [1]
C0008961
Serious Adverse Event
Descripción

serious adverse event

Tipo de datos

text

Alias
UMLS CUI [1]
C1519255
Onset Date and Time
Descripción

serious adverse event onset

Tipo de datos

datetime

Alias
UMLS CUI [1]
C2826806
End Date and Time
Descripción

serious adverse event end

Tipo de datos

datetime

Alias
UMLS CUI [1]
C2826793
Outcome
Descripción

If subject died, please inform GSK within 24 hours and complete Form D.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1519255
Event Course
Descripción

serious adverse event course

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0750729
Number of episodes
Descripción

serious adverse event episodes

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C4086638
Intensity (maximum)
Descripción

serious adverse event intensity

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0518690
Specify reason(s) for considering this a serious AE. Mark all that apply.
Descripción

serious adverse event reason

Tipo de datos

text

Alias
UMLS CUI [1]
C3828190
Please specify other:
Descripción

serious adverse event reason

Tipo de datos

text

Alias
UMLS CUI [1]
C3828190
Action Taken with Respect to Investigational Drug
Descripción

action taken

Tipo de datos

text

Alias
UMLS CUI [1]
C2826626
Did the SAE abate?
Descripción

SAE abate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C3853704
If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)?
Descripción

study medication reintroduced

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0580673
If yes, did SAE recur?
Descripción

SAE recur

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0034897
Relationship to Investigational Drug
Descripción

relationship to investigational drug

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0439849
The SAE is probably associated with:
Descripción

SAE association

Tipo de datos

text

Alias
UMLS CUI [1]
C1706737
Please specify:
Descripción

SAE association

Tipo de datos

text

Alias
UMLS CUI [1]
C1706737
Corrective Therapy
Descripción

If YES, please record on Concomitant Medication form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0087111
Was subject withdrawn due to this AE?
Descripción

subject withdrawn due to adverse event

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0877248
Remarks
Descripción

Please provide a brief narrative description of the SAE, attaching extra pages e.g. hospital discharge summary if necessary)

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0947611
If applicable, was randomisation code broken at investigational site?
Descripción

randomisation code broken

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0034656
Randomisation/ Study Medication Number
Descripción

randomisation number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Relevant Laboratory Data
Descripción

Relevant Laboratory Data

Alias
UMLS CUI-1
C0022885
Test
Descripción

laboratory test

Tipo de datos

text

Alias
UMLS CUI [1]
C0022885
Date
Descripción

laboratory date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0022877
UMLS CUI [1,2]
C0011008
Value
Descripción

laboratory value

Tipo de datos

text

Alias
UMLS CUI [1]
C0022877
Units
Descripción

unit

Tipo de datos

text

Alias
UMLS CUI [1]
C1519795
Normal Range
Descripción

normal range

Tipo de datos

text

Alias
UMLS CUI [1]
C0086715
Form D
Descripción

Form D

Alias
UMLS CUI-1
C1306577
Certified Cause of Death
Descripción

cause of death

Tipo de datos

text

Alias
UMLS CUI [1]
C0007465
Date of Death
Descripción

date of death

Tipo de datos

date

Alias
UMLS CUI [1]
C1148348
Was an autopsy done?
Descripción

autopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004398
If YES, please summarize findings (include diagnosis):
Descripción

autopsy

Tipo de datos

text

Alias
UMLS CUI [1]
C0004398
Investigator Comment LOG
Descripción

Investigator Comment LOG

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C0947611
Date of comment
Descripción

date of comment

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C0011008
CRF page number if applicable
Descripción

page number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1704732
Comment
Descripción

comment

Tipo de datos

text

Alias
UMLS CUI [1]
C0947611
Investigator's Checklist
Descripción

Investigator's Checklist

Alias
UMLS CUI-1
C1707357
UMLS CUI-2
C0008961
Check all Adverse Event forms are up to date and complete
Descripción

adverse event forms completed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0920316
UMLS CUI [1,3]
C0205197
Check that the Concomitant Medication form is up to date
Descripción

concomitant medication form up to date

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0920316
UMLS CUI [1,3]
C0237400
Check that all appropriate pages are signed (thus indicating completition) an dated
Descripción

signing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519316
Check that laboratory results are included
Descripción

laboratory results included

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C0920316
Volver a la parte superior de la página

Similar models

GW597599 and paroxetine on the pharmacokinetics of midazolam and dextromethorphan 100716 Follow-Up Serious Adverse Event, Form D, Investigator Comment Log, Investigator's Statement

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Serious Adverse Event (SAE)
C1519255 (UMLS CUI-1)
person reporting sae
Item
Person Reporting SAE
text
C0008961 (UMLS CUI [1])
serious adverse event
Item
Serious Adverse Event
text
C1519255 (UMLS CUI [1])
serious adverse event onset
Item
Onset Date and Time
datetime
C2826806 (UMLS CUI [1])
serious adverse event end
Item
End Date and Time
datetime
C2826793 (UMLS CUI [1])
Item
Outcome
text
C1705586 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
serious adverse event outcome
Code List
Outcome
CL Item
Resolved (Resolved)
CL Item
Ongoing (Ongoing)
CL Item
Died (Died)
Item
Event Course
text
C1519255 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
serious adverse event course
Code List
Event Course
CL Item
Intermittent (Intermittent)
CL Item
Constant (Constant)
serious adverse event episodes
Item
Number of episodes
integer
C1519255 (UMLS CUI [1,1])
C4086638 (UMLS CUI [1,2])
Item
Intensity (maximum)
text
C1519255 (UMLS CUI [1,1])
C0518690 (UMLS CUI [1,2])
serious adverse event intensity
Code List
Intensity (maximum)
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
Item
Specify reason(s) for considering this a serious AE. Mark all that apply.
text
C3828190 (UMLS CUI [1])
serious adverse event reason
Code List
Specify reason(s) for considering this a serious AE. Mark all that apply.
CL Item
results in Death (A)
CL Item
life threatening (B)
CL Item
requires hospitalisation or prolongation of existing hospitalisation (C)
CL Item
results in disability/ incapacity (D)
CL Item
congenital anomaly/ birth defect (E)
CL Item
other (see definition) (F)
serious adverse event reason
Item
Please specify other:
text
C3828190 (UMLS CUI [1])
Item
Action Taken with Respect to Investigational Drug
text
C2826626 (UMLS CUI [1])
action taken
Code List
Action Taken with Respect to Investigational Drug
CL Item
None (None)
CL Item
Dose reduced (Dose reduced)
CL Item
Dose increased (Dose increased)
CL Item
Drug interrupted/restarted (Drug interrupted/restarted)
CL Item
Drug stopped (Drug stopped)
SAE abate
Item
Did the SAE abate?
boolean
C1519255 (UMLS CUI [1,1])
C3853704 (UMLS CUI [1,2])
study medication reintroduced
Item
If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)?
boolean
C0013230 (UMLS CUI [1,1])
C0580673 (UMLS CUI [1,2])
SAE recur
Item
If yes, did SAE recur?
boolean
C1519255 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
Item
Relationship to Investigational Drug
text
C1519255 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
relationship to investigational drug
Code List
Relationship to Investigational Drug
CL Item
Not related (Not related)
CL Item
Unlikely (Unlikely)
CL Item
Suspected (reasonable possibility) (Suspected (reasonable possibility))
CL Item
Probable (Probable)
Item
The SAE is probably associated with:
text
C1706737 (UMLS CUI [1])
SAE association
Code List
The SAE is probably associated with:
CL Item
Protocol design or procedures (but not to study drug) (Protocol design or procedures (but not to study drug))
CL Item
Another condition (e.g. condition under study, intercurrent illness) (Another condition (e.g. condition under study, intercurrent illness))
CL Item
Another drug (Another drug)
SAE association
Item
Please specify:
text
C1706737 (UMLS CUI [1])
corrective therapy
Item
Corrective Therapy
boolean
C1519255 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
subject withdrawn due to adverse event
Item
Was subject withdrawn due to this AE?
boolean
C2349954 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
SAE remarks
Item
Remarks
text
C1519255 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
randomisation code broken
Item
If applicable, was randomisation code broken at investigational site?
boolean
C0034656 (UMLS CUI [1])
randomisation number
Item
Randomisation/ Study Medication Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item Group
Relevant Laboratory Data
C0022885 (UMLS CUI-1)
laboratory test
Item
Test
text
C0022885 (UMLS CUI [1])
laboratory date
Item
Date
date
C0022877 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
laboratory value
Item
Value
text
C0022877 (UMLS CUI [1])
unit
Item
Units
text
C1519795 (UMLS CUI [1])
normal range
Item
Normal Range
text
C0086715 (UMLS CUI [1])
Item Group
Form D
C1306577 (UMLS CUI-1)
cause of death
Item
Certified Cause of Death
text
C0007465 (UMLS CUI [1])
date of death
Item
Date of Death
date
C1148348 (UMLS CUI [1])
autopsy
Item
Was an autopsy done?
boolean
C0004398 (UMLS CUI [1])
autopsy
Item
If YES, please summarize findings (include diagnosis):
text
C0004398 (UMLS CUI [1])
Item Group
Investigator Comment LOG
C0008961 (UMLS CUI-1)
C0947611 (UMLS CUI-2)
date of comment
Item
Date of comment
date
C0947611 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
page number
Item
CRF page number if applicable
integer
C1704732 (UMLS CUI [1])
comment
Item
Comment
text
C0947611 (UMLS CUI [1])
Item Group
Investigator's Checklist
C1707357 (UMLS CUI-1)
C0008961 (UMLS CUI-2)
adverse event forms completed
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1,1])
C0920316 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
concomitant medication form up to date
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1,1])
C0920316 (UMLS CUI [1,2])
C0237400 (UMLS CUI [1,3])
signing
Item
Check that all appropriate pages are signed (thus indicating completition) an dated
boolean
C1519316 (UMLS CUI [1])
laboratory results included
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1,1])
C0920316 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial